{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psoriasis&page=18", "query": { "condition": "Psoriasis", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 924, "total_pages": 93, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psoriasis&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psoriasis&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T18:20:02.836Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02326298", "title": "An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Plaque Psoriasis" ], "interventions": [ { "name": "Certolizumab Pegol", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "UCB Biopharma S.P.R.L.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 234, "start_date": "2014-12-16", "completion_date": "2018-10-24", "has_results": true, "last_update_posted_date": "2019-11-07", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 8, "location_summary": "San Diego, California • West Des Moines, Iowa • Baton Rouge, Louisiana + 5 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "West Des Moines", "state": "Iowa" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02326298" }, { "nct_id": "NCT01536938", "title": "LEO 90100 in the Treatment of Psoriasis Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis Vulgaris" ], "interventions": [ { "name": "LEO 90100", "type": "DRUG" }, { "name": "Calcipotriol", "type": "DRUG" }, { "name": "Betamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 303, "start_date": "2012-05", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2025-03-07", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 33, "location_summary": "Hot Springs, Arkansas • Los Angeles, California • Oceanside, California + 26 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01536938" }, { "nct_id": "NCT02993471", "title": "A Study of Ixekizumab in Participants With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Drug Cocktail", "type": "DRUG" }, { "name": "Ixekizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2016-12-22", "completion_date": "2017-11-21", "has_results": true, "last_update_posted_date": "2019-03-12", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 3, "location_summary": "Anaheim, California • DeLand, Florida • High Point, North Carolina", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "High Point", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02993471" }, { "nct_id": "NCT00773734", "title": "Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis", "Plaque-type Psoriasis" ], "interventions": [ { "name": "Apremilast 10mg", "type": "DRUG" }, { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 352, "start_date": "2008-09-01", "completion_date": "2015-05-20", "has_results": true, "last_update_posted_date": "2020-05-07", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 20, "location_summary": "Fresno, California • Los Angeles, California • Redwood City, California + 16 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Wilmington", "state": "Delaware" }, { "city": "Ocala", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00773734" }, { "nct_id": "NCT05655299", "title": "VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "VTX958 Dose A", "type": "DRUG" }, { "name": "VTX958 Dose B", "type": "DRUG" }, { "name": "VTX958 Dose C", "type": "DRUG" }, { "name": "VTX958 Dose D", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ventyx Biosciences, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 222, "start_date": "2022-11-17", "completion_date": "2023-12-20", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Bryant, Arkansas + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bryant", "state": "Arkansas" }, { "city": "North Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05655299" }, { "nct_id": "NCT02387853", "title": "Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis Vulgaris" ], "interventions": [ { "name": "LEO 90100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 117, "start_date": "2016-03", "completion_date": "2018-03-28", "has_results": true, "last_update_posted_date": "2025-03-10", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 6, "location_summary": "Palo Alto, California • Santa Rosa, California • Fort Gratiot, Michigan + 2 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Fort Gratiot", "state": "Michigan" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02387853" }, { "nct_id": "NCT07321873", "title": "A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "JNJ-88545223", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2026-01-15", "completion_date": "2027-08-02", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 18, "location_summary": "Searcy, Arkansas • Huntington Beach, California • San Diego, California + 15 more", "locations": [ { "city": "Searcy", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Cutler Bay", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07321873" }, { "nct_id": "NCT00267956", "title": "An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "CNTO 1275 63 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Centocor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 146, "start_date": "2005-12", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2013-06-05", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 12, "location_summary": "Macon, Georgia • Boise, Idaho • Normal, Illinois + 9 more", "locations": [ { "city": "Macon", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" }, { "city": "Normal", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Covington", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00267956" }, { "nct_id": "NCT06095102", "title": "A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "JNJ-77242113", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 311, "start_date": "2023-10-12", "completion_date": "2027-02-17", "has_results": true, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 28, "location_summary": "Scottsdale, Arizona • Fort Smith, Arkansas • Encinitas, California + 24 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Alpharetta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06095102" }, { "nct_id": "NCT06979453", "title": "A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Deucravacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 366, "start_date": "2025-12-03", "completion_date": "2034-08-12", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-23T18:20:02.836Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Fountain Valley, California + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06979453" } ] }